Joan How
Brigham and Women's Hospital
30 Papers
64 Citations
Joan How is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Medicine & Essential thrombocythemia. The author has an hindex of 10, co-authored 22 publications. Previous affiliations of Joan How include Washington University in St. Louis & Yale University.
Chat about Author
Papers
Mutant calreticulin in myeloproliferative neoplasms.
TL;DR: The current understanding of the biology underpinning mutant CALR driven MPN is reviewed, clinical implications are discussed, and future therapeutic approaches are highlighted.
70
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.
Vivek Naranbhai,Vivek Naranbhai,Claire A. Pernat,Alexander Gavralidis,Alexander Gavralidis,Kerri St. Denis,Evan C. Lam,Laura Spring,Steven J. Isakoff,Jocelyn R. Farmer,Leyre Zubiri,Gabriela S. Hobbs,Joan How,Joan How,Andrew M. Brunner,Amir T. Fathi,Jennifer L Peterson,Mustafa Sakhi,Grace Hambelton,Elyssa Denault,Lindsey Mortensen,Lailoo A Perriello,Marissa N Bruno,Brittany Y Bertaux,Aleigha Lawless,Monica A Jackson,Elizabeth Niehoff,Caroline Barabell,Christian N Nambu,Erika Nakajima,Trenton Reinicke,C. Bowes,Cristhian J Berrios-Mairena,Onosereme Ofoman,Grace Kirkpatrick,Julia Thierauf,Kerry L. Reynolds,Henning Willers,Wilfredo-Garcia Beltran,Wilfredo-Garcia Beltran,Anand S. Dighe,Rebecca R. Saff,Kimberly G. Blumenthal,Ryan J. Sullivan,Yi-Bin Chen,Arthur Y. Kim,Aditya Bardia,Alejandro B. Balazs,A. John Iafrate,Justin F. Gainor +49 more
TL;DR: This article performed a prospective cohort study of adults with solid-organ or hematologic cancers to evaluate anti-SARS-CoV-2 immunoglobulin A/M/G spike antibodies, neutralization, and reactogenicity ≥ 7 days following two doses of mRNA-1273, BNT162b2, or one dose of Ad26.COV2.
67
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
TL;DR: Both neurologists and non-neurologists should be familiar with the most commonly implicated agents, symptoms, risk factors, and clinical course of chemotherapy-associated PRES, given its favorable prognosis with appropriate management.
60
What are the links between maternal social status, hippocampal function, and HPA axis function in children?
Margaret A. Sheridan,Joan How,Melanie Araujo,Michelle A. Schamberg,Charles A. Nelson,Charles A. Nelson +5 more
TL;DR: An association is observed between both maternal self-rated social status and hippocampal activation in children and between maternalself-ratedsocial status and salivary cortisol in children.
55
Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature.
Joan How,Gabriela S. Hobbs +1 more
TL;DR: Interferon has re-emerged as an important option in MPN patients, with future studies seeking to re-establish its place in the existing treatment algorithm for MPN, and potentially expanding its use for novel indications and combination therapies.
53